DRMA
Dermata Therapeutics Inc

3,519
Mkt Cap
$4.79M
Volume
47,663.00
52W High
$23.70
52W Low
$1.29
PE Ratio
-0.07
DRMA Fundamentals
Price
$1.37
Prev Close
$1.35
Open
$1.35
50D MA
$2.26
Beta
0.37
Avg. Volume
1.85M
EPS (Annual)
-$80.32
P/B
0.29
Rev/Employee
$0.00
$1.10
Loading...
Loading...
Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410. The company was founded by David F. Hale and Gerald T. Proehl on December 8, 2014 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
8

Frequently Asked Questions

What is Market Cap of Dermata Therapeutics Inc?
What is the 52-week high for Dermata Therapeutics Inc?
What is the 52-week low for Dermata Therapeutics Inc?
What is Dermata Therapeutics Inc stock price today?
What was Dermata Therapeutics Inc stock price yesterday?
What is the PE ratio of Dermata Therapeutics Inc?
What is the Price-to-Book ratio of Dermata Therapeutics Inc?
What is the 50-day moving average of Dermata Therapeutics Inc?
How many employees does Dermata Therapeutics Inc have?

Latest DRMA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.